IDEXX Laboratories Inc (NASDAQ:IDXX)

395.16
BATS BZX Real-Time Price
As of 2:39pm ET
 -1.77 / -0.45%
Today’s Change
318.50
Today|||52-Week Range
695.18
-39.99%
Year-to-Date
3 No-Brainer Stocks to Buy in a Correction
10:31am / MotleyFool.com - Paid Partner Content
IDEXX (IDXX) Q2 Earnings Surpass Estimates, 2022 View Down
Aug 02 / Zacks.com - Paid Partner Content
Idexx Laboratories (IDXX) Q2 2022 Earnings Call Transcript
Aug 02 / MotleyFool.com - Paid Partner Content
Idexx Laboratories (IDXX) Surpasses Q2 Earnings Estimates
Aug 02 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close396.93
Today’s open397.83
Day’s range393.88 - 398.97
Volume11,178
Average volume (3 months)659,063
Market cap$33.9B
Data as of 2:39pm ET, 08/12/2022

Growth & Valuation

Earnings growth (last year)+28.24%
Earnings growth (this year)-7.56%
Earnings growth (next 5 years)+9.49%
Revenue growth (last year)+18.79%
P/E ratio51.1
Price/Sales17.73
Price/Book49.98

Competitors

 Today’s
change
Today’s
% change
GMABGenmab A/S-0.78-2.07%
--Quidelortho Corp+4.50+5.39%
QDELQuidelortho Corp-2.79-3.20%
LNTHLantheus Holdings In...-0.77-0.92%
Data as of 2:40pm ET, 08/12/2022

Financials

Next reporting dateNovember 1, 2022
EPS forecast (this quarter)$2.05
Annual revenue (last year)$3.2B
Annual profit (last year)$744.8M
Net profit margin23.17%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Westbrook, Maine

Forecasts